Jasper Therapeutics (JSPR)
(Real Time Quote from BATS)
$18.15 USD
+0.05 (0.28%)
Updated Aug 16, 2024 12:24 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -1.08 |
EPS Last Quarter | -0.97 |
Last EPS Surprise | 11.01% |
ABR | 1.10 |
Earnings ESP
|
-1.77% |
---|---|
Current Year | -4.15 |
Next Year | -4.03 |
EPS (TTM) | -5.10 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 44.00M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 44.00M |
Low Estimate | NA | NA | NA | 44.00M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.08 | -1.11 | -4.15 | -4.03 |
# of Estimates | 6 | 5 | 7 | 6 |
Most Recent Consensus | -1.05 | -0.92 | -3.88 | -4.05 |
High Estimate | -0.98 | -0.92 | -3.88 | -2.33 |
Low Estimate | -1.15 | -1.29 | -4.44 | -5.00 |
Year ago EPS | -1.60 | -1.50 | -6.18 | -4.15 |
Year over Year Growth Est. | 32.50% | 26.00% | 32.85% | 2.87% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 3 | 4 | 5 | 5 |
Up Last 30 Days | 3 | 4 | 5 | 5 |
Up Last 60 Days | 2 | 3 | 4 | 4 |
Down Last 7 Days | 1 | 1 | 1 | 1 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.08 | -1.11 | -4.15 | -4.03 |
7 Days Ago | -1.17 | -1.20 | -4.41 | -4.28 |
30 Days Ago | -1.17 | -1.20 | -4.41 | -4.28 |
60 Days Ago | -1.14 | -1.19 | -4.36 | -4.12 |
90 Days Ago | -1.14 | -1.19 | -4.35 | -4.12 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.09 | -1.11 | -4.19 | -4.03 |
Zacks Consensus Estimate | -1.08 | -1.11 | -4.15 | -4.03 |
Earnings ESP | -1.77% | 0.00% | -1.03% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.97 | -1.03 | -1.50 | -1.60 | NA |
Estimate | -1.09 | -1.26 | -1.65 | -1.50 | NA |
Difference | 0.12 | 0.23 | 0.15 | -0.10 | 0.10 |
Surprise | 11.01% | 18.25% | 9.09% | -6.67% | 7.92% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more